olmesartan has been researched along with cyanoginosin lr in 1 studies
Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (cyanoginosin lr) | Trials (cyanoginosin lr) | Recent Studies (post-2010) (cyanoginosin lr) |
---|---|---|---|---|---|
841 | 185 | 554 | 1,533 | 1 | 900 |
Protein | Taxonomy | olmesartan (IC50) | cyanoginosin lr (IC50) |
---|---|---|---|
Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.0012 | |
Protein phosphatase 1A | Homo sapiens (human) | 0.003 | |
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit | Homo sapiens (human) | 0.0302 | |
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform | Homo sapiens (human) | 0.0001 | |
Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B | Gallus gallus (chicken) | 0.0016 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ekins, S; Williams, AJ; Xu, JJ | 1 |
1 other study(ies) available for olmesartan and cyanoginosin lr
Article | Year |
---|---|
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |